Fed Regist. 2000 Aug 3;65(150):47654-60.
The Nuclear Regulatory Commission (NRC) is revising its 1979 policy statement on the medical use of byproduct material. These revisions are one component of the Commission's overall program for revising its regulatory framework for medical use, including its regulations that govern the medical use of byproduct material. The overall goals of this program are to focus NRC regulation of medical use on those medical procedures that pose the highest risk and to structure its regulations to be risk-informed and more performance-based, consistent with NRC's "Strategic Plan for Fiscal Year 1997-Fiscal Year 2002." The policy informs NRC licensees, other Federal and State agencies, and the public of the Commission's general intentions in regulating the medical use of byproduct material.
核管理委员会（NRC）正在修订其1979年关于副产品材料医疗用途的政策声明。这些修订是委员会修订其医疗用途监管框架总体计划的一部分，包括其管理副产品材料医疗用途的规定。该计划的总体目标是将NRC对医疗用途的监管重点放在那些风险最高的医疗程序上，并根据NRC的“1997财年至2002财年战略计划”，构建风险告知型和更注重绩效的法规。该政策向NRC的持证人、其他联邦和州机构以及公众通报了委员会在监管副产品材料医疗用途方面的总体意图。
